These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15962839)

  • 21. Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion.
    Kaul DK; Nagel RL; Chen D; Tsai HM
    Blood; 1993 May; 81(9):2429-38. PubMed ID: 8481522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of polynitroxylated albumin (PNA) and tempol on ischemia/reperfusion injury: intravital microscopic study in the dorsal skinfold chamber of the Syrian golden hamster.
    Steinbauer M; Guba M; Büchner M; Farkas S; Anthuber M; Jauch KW
    Shock; 2000 Aug; 14(2):163-8. PubMed ID: 10947161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid exhibit multiple modalities of benefit for the vascular pathobiology of sickle transgenic mice.
    Hebbel RP; Vercellotti GM; Pace BS; Solovey AN; Kollander R; Abanonu CF; Nguyen J; Vineyard JV; Belcher JD; Abdulla F; Osifuye S; Eaton JW; Kelm RJ; Slungaard A
    Blood; 2010 Mar; 115(12):2483-90. PubMed ID: 20053759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickle cell vasoocclusion: many issues and some answers.
    Kaul DK; Nagel RL
    Experientia; 1993 Jan; 49(1):5-15. PubMed ID: 8428611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion.
    Frenette PS
    Microcirculation; 2004 Mar; 11(2):167-77. PubMed ID: 15280090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation.
    de Franceschi L; Baron A; Scarpa A; Adrie C; Janin A; Barbi S; Kister J; Rouyer-Fessard P; Corrocher R; Leboulch P; Beuzard Y
    Blood; 2003 Aug; 102(3):1087-96. PubMed ID: 12689931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.
    Finnegan EM; Barabino GA; Liu XD; Chang HY; Jonczyk A; Kaul DK
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1038-45. PubMed ID: 17483236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.
    Belcher JD; Chen C; Nguyen J; Zhang P; Abdulla F; Nguyen P; Killeen T; Xu P; O'Sullivan G; Nath KA; Vercellotti GM
    Antioxid Redox Signal; 2017 May; 26(14):748-762. PubMed ID: 26914345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of arginine on oxidative stress in transgenic sickle mouse models.
    Dasgupta T; Hebbel RP; Kaul DK
    Free Radic Biol Med; 2006 Dec; 41(12):1771-80. PubMed ID: 17157180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antioxidants and nitric oxide on TNF-alpha-induced adhesion molecule expression and NF-kappaB activation in human dermal microvascular endothelial cells.
    Jiang MZ; Tsukahara H; Ohshima Y; Todoroki Y; Hiraoka M; Maeda M; Mayumi M
    Life Sci; 2004 Jul; 75(10):1159-70. PubMed ID: 15219804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quercetin Completely Ameliorates Hypoxia-Reoxygenation-Induced Pathophysiology Severity in NY1DD Transgenic Sickle Mice: Intrinsic Mild Steady State Pathophysiology of the Disease in NY1DD Is Also Reversed.
    Thangaswamy S; Branch CA; Ambadipudi K; Acharya SA
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.
    Keleku-Lukwete N; Suzuki M; Otsuki A; Tsuchida K; Katayama S; Hayashi M; Naganuma E; Moriguchi T; Tanabe O; Engel JD; Imaizumi M; Yamamoto M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12169-74. PubMed ID: 26371321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semisynthetic supra plasma expanders: a new class of therapeutics to improve microcircualtion in sickle cell anaemia.
    Meng F; Kaul D; Thangaswamy S; Bhutoria S; Gerfen G; Branch C; Intaglietta M; Acharya SA
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):73-82. PubMed ID: 30663492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable sickle cell discocytes.
    Fabry ME; Fine E; Rajanayagam V; Factor SM; Gore J; Sylla M; Nagel RL
    Blood; 1992 Mar; 79(6):1602-11. PubMed ID: 1547349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease.
    Beckman JD; Belcher JD; Vineyard JV; Chen C; Nguyen J; Nwaneri MO; O'Sullivan MG; Gulbahce E; Hebbel RP; Vercellotti GM
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1243-53. PubMed ID: 19617415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokines in sickle cell disease.
    Pathare A; Kindi SA; Daar S; Dennison D
    Hematology; 2003 Oct; 8(5):329-37. PubMed ID: 14530175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.
    Turhan A; Weiss LA; Mohandas N; Coller BS; Frenette PS
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3047-51. PubMed ID: 11880644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cobalt chloride-induced signaling in endothelium leading to the augmented adherence of sickle red blood cells and transendothelial migration of monocyte-like HL-60 cells is blocked by PAF-receptor antagonist.
    Sultana C; Shen Y; Johnson C; Kalra VK
    J Cell Physiol; 1999 Apr; 179(1):67-78. PubMed ID: 10082134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice.
    Keleku-Lukwete N; Suzuki M; Panda H; Otsuki A; Katsuoka F; Saito R; Saigusa D; Uruno A; Yamamoto M
    Blood Adv; 2019 Apr; 3(8):1285-1297. PubMed ID: 31015205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.